The Pharma Data
SEPTEMBER 1, 2021
Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The engineered cells reduced inflammation and prevented a type of damage to bone, known as bone erosion, in a mouse model of rheumatoid arthritis. . Science Advances, Sept.
The Pharma Data
NOVEMBER 4, 2020
(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
FEBRUARY 13, 2023
With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA. As a result, there is an evident increase in the demand for mRNA manufacturing capacity.
Roots Analysis
OCTOBER 22, 2023
In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. It is important to highlight that IVT mRNAs are structurally similar to natural mRNAs and can be used to express proteins through genetic engineering.
Drug Discovery World
NOVEMBER 8, 2023
Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’.
Drug Discovery World
NOVEMBER 9, 2023
The luncheon presentations include: Juan Quintana, PhD, Technical Sales Manager, ACROBiosystems, on: ‘Manufacturing high quality proteins for complex applications’. Marine Houdou, Genetic Engineering Specialist, Polyplus, on: ‘From modular DNA assembly to recombinant protein production at Polyplus’. Filip Borgions, Ph.D,
Expert insights. Personalized for you.
52 
Let's personalize your content